TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Läkarna Glaumann AB
Closing information (x1000 EUR)
| Closing information | 2025/12 | 2024/12 | 2023/12 |
| Turnover |
69
|
89 | |
| Financial expenses |
0
|
0 | |
| Earnings before taxes |
7
|
37 | |
| EBITDA |
7
|
37 | |
| Total assets |
34
|
64 | |
| Current assets |
34
|
64 | |
| Current liabilities |
16
|
25 | |
| Equity capital |
16
|
38 | |
| - share capital |
4
|
5 | |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Solvency |
47.1%
|
59.4% | |
| Turnover per employee |
69
|
89 | |
| Profit as a percentage of turnover |
10.1%
|
41.6% | |
| Return on assets (ROA) |
20.6%
|
57.8% | |
| Current ratio |
212.5%
|
256.0% | |
| Return on equity (ROE) |
43.8%
|
97.4% | |
| Change turnover |
-17
|
79 | |
| Change turnover % |
-51%
|
-20%
|
845% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.